Pharmaceutical composition for the treatment of CNS and other disorders
US6881734B2 · kind B2 · utility
4Cited by
0References
10Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 27, 2004 |
| Grant date | Apr 19, 2005 |
| Priority date | — |
| Expiry date | Apr 27, 2024 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P25/36
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to a method of treating disorders of the Central Nervous System (CNS) and other disorders in a mammal, including a human, by administering to the mammal a CNS-penetrant α7 nicotinic receptor agonist. It also relates to pharmaceutical compositions containing a pharmaceutically acceptable carrier and a CNS-penetrant α7 nicotinic receptor agonist.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.